Introduction
observed the beneficial effect of amantadine in a patient with Parkinsonism who had been given the drug as a prophylactic against influenza. They subsequently reported its use in 163 cases. Their observations have since been confirmed by Parkes, Zilkha, Calver, and Knill-Jones (1970) in a controlled trial of 37 patients treated for two weeks.
The aim of the present study was to investigate a larger group of patients and to determine the place of amantadine in the treatment of Parkinsonian symptoms.
Patients and Methods
Sixty-two outpatients (24 men and 38 women) with Parkinsonism were admitted to trial. Twenty-nine were allocated randomly to receive amantadine and 33 to receive placebo capsules. The randomization was stratified with regard to age, sex, previous thalamotomy, and initial severity, as judged by our scoring system for rigidity, tremor, akinesia, and functional disability, and for tests of motor facility (occupational therapy tests). The age of the patients ranged from 43 to 74 years in the amantadine group (group A) and from 40 to 74 years in the placebo group (group B). There were 10 men (34%) in group A and 14 (43%) in group B.
Out of the 62 patients, 58 completed the trial-28 in group A and 30 in group B. One patient in group A died of pneumonia and three in group B failed to attend after the initial assessment, after the second week, and after the third week, respectively. In group A 17 cases were judged to be of idiopathic paralysis agitans, five were arteriosclerotic, and six post-encephalitic; seven patients had had previous thalamo-* Medical Registrar. tomy. In group B 17 cases were idiopathic, six arteriosclerotic, and seven post-encephalitic; nine patients had had previous thalamotomy. Scores for severity of tremor, rigidity, and akinesia were given by a clinical observer and those for functional disability and occupational therapy tests were allocated by the occupational therapist. Neither the clinician nor the occupational therapist knew which patients were on the test drug; this was known only by the pharmacist who dispensed the capsules according to the instructions of the statistician.
Scoring System
Scores for severity of rigidity and tremor were allotted on the following basis: severe = 3, moderate = 2, slight = 1, and nil = 0. Severity of rigidity and tremor were recorded for each of the four limbs and for the trunk. The possible total score for each sign was 15.
Akinesia was assessed by nine factors: eight on a threepoint severity scale (0, 1, or 2) and one on a five-point scale (0, 1, 2, 3, or 4), the total score being 20: Assessments were made at weeks 0, 1, 2, 3, 4, and 8 by the clinician. Social disability was assessed by 10 aspects on a threepoint severity scale (0, 1, or 2): Assessments were made by the occupational therapist at weeks 0, 4, and 8. Each assessment by the clinician and by the occupational therapist gave a total of 50 possible disability scores. The patient's subjective assessment and side effects were also recorded. Analysis was done by an independent statistician.
Drugs
The amantadine (100 mg.) and placebo were presented in identical red capsules and were taken each morning and midday for four weeks. The patients continued to take their other anti-Parkinsonian drugs throughout the period of the trial. After four weeks amantadine or placebo was withdrawn and the patients were reassessed at eight weeks. The patients were instructed to bring back their remaining capsules (for counting).
Results
For the purpose of statistical analysis the progress of the two groups was expressed as percentage of the initial disability. The initial score was taken as 100 and the actual initial disability scores are given in parentheses in Table I Tremor is difficult to assess in outpatients as it is unfavourably influenced by hospital attendance and many patients stated that their tremor was less pronounced at home. The patients' reactions to the drug were favourable in 79',, a figure similar to that found by Parkes et al. (1970) .
We were impressed by the speed of action of amantadine, optimum benefit occurring after the first two weeks of treatment. This finding is in agreement with that of Parkes et al. By the fourth week, however, benefit was less significant and a decline in benefit was evident. The mechanism of this falling off needs further investigation. Two patients obtained more than 50% benefit with the drug. No comparable degree of improvement was obtained in those of group B. Such an improvement evident in two weeks makes a trial of this drug worth while. We found no relationship between response and aetiology. Like previous workers we found that tremor responded less well than akinesia, and therefore consider that stereotaxis has a major role to offer the younger patient with unilateral Parkinson's disease. Side effects on a 200-mg. daily dose were insignificant and disappeared with continued medication. While some side effects resembled th e of the anticholinergic drugs-for example, blurred vis.Tli and dry mouth-one patient had postural hypotension esembling the effect of L-dopa (Calne et al., 1970) . Only cc.L-patient complained of excitement and sleeplessness. Summation with benzhexol or orphenadrine may cause visual hallucinations, and reduction of the dose of these drugs may be needed when amantadine is prescribed.
All patients except two were taking conventional antiParkinsonian drugs and the trial established the additive value of amantadine. Its value as a single treatment for Parkinsonism is as yet undetermined (Alstead, 1970 ADDENDUM.-Since this paper was written two further articles have been published: K. R. Hunter, G. M. Stem, D. R. Laurence, and P. Armitage (Lancet, 1970 (Lancet, , 1, 1127 and J. D.
Parkes, K. J. Zilkha, P. Marsden, R. C. H. Baxter, and R. P. Knill-Jones (Lancet, 1970 , 1, 1130 
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Chest complications following paramedian incisions in the abdomen, and particularly those following gastric surgery, increase mortality and morbidity in the postoperative period. Their incidence, which has not fallen as dramatically as expected with the recent improvements in anaesthesia and surgery, varies from 85.60/,% (Collins et al., 1968) to 34 "a (Palmer, 1955) and 30%,, (Stringer, 1947) . The causes of these complications include position alone (Prys-Roberts ct al., 1967), infection (Collins et al., 1968) , diaphragmatic and abdominal splinting (Nunn et al., 1965) , pneumoperitoneum, decrease in pulmonary compliance (Lewis and Welch, 1965) , reduction of respiratory amplitude (Ngai, 1967) , and loss of periodic deep inspiration under anaesthesia (Bendixen et al., 1964) . The problem is certainly multifaceted, and the answer complex.
I undertook this study after observing that patients who had a metabolic acidosis on the first postoperative day were those who developed atelectasis and lobar collapse. Therefore if it was possible to prevent this acidosis the incidence of chest complications might fall.
Patients and Methods
The study group, comprising 181 patients undergoing major abdominal surgery, was divided randomly into two * Lecturer in Orthopaedics, Bristol Royal Infirmary, Bristol.
groups. These were not matched for age, sex, or severity of the surgical procedure. All the patients came from the same group of wards and received identical nursing care and physiotherapy. The same surgeons, anaesthetists, and nursing teams carried out the operations, no record being made of individual variation in technique; all operations lasted at least three-quarters of an hour.
The two groups were comparable in age, sex distribution, and type of operation, analgesia, and anaesthetic technique, the only difference being that the control group (group 1) did not receive intravenous bicarbonate, whereas the other group (group 2) did (Table I) .
Bicarbonate.-All the patients in group 2 received 100 mEq of sodium bicarbonate (an 8-4 0/ solution prepared by the pharmacological department of St. James's Hospital), which was infused intravenously in 10 minutes, two hours after surgery and then eight-hourly for two doses, a total of 300 mEq being given in the first 18 hours postoperatively. This rate of infusion was arrived at empirically, as the dangers of overrapid infusion are well known, and too slow a rate has no effect on acid-base balance.
Preoperative Assessment.-This was based on routine physical examination, history-taking, and chest radiographs. Tidal 
